Proceedings: Extracellular release of cathepsin D from cells in human normal and rheumatoid.

Authors:
  • APA.R Poole
    A.R Poole
  • RHR.M Hembry
    R.M Hembry
  • JDJ.T Dingle
    J.T Dingle
  • IPI Pinder
    I Pinder
  • ERE.F Ring
    E.F Ring
  • JCJ Cosh
    J Cosh

Abstract
Heberden Society 405 a higher proportion of the aldimine crosslinks than the centre of the plaque, and, furthermore, the proportion was considerably reduced in inactive scleroderma patients. The presence of these aldimine crosslinks establishes that new collagen is being laid down in the skin of sclerodermatous patients. Cleavage of the crosslinks stabilizing the collagen fibre may relieve the symptoms by softening the skin. D-penicillamine is capable of cleaving the aldimine cross-links of newly formed collagen but not the stable cross-links of mature collagen. Clearly, D-penicillamine will only be effective on active scieroderma, and previous conflicting evidence on the value of this drug may be partly due to a failure to differentiate its effects on mature and immature collagen. In addition, in vitro tissue culture studies on sclerodermatous skin have shown a partial inhibition of collagen synthesis in the presence of Dpenicillamine (Herbert, Jayson, Bailey, and Lindberg, 1974). Two patients with active scleroderma were treated with D-penicillamine (1-5 g/day) and followed with sequential biopsies over 9 months. In both cases a significant decrease in the proportion of aldimine cross links was observed, together with a definite improvement in the clinical manifestations of the disease.

This publication has 1 reference indexed in Scilit: